There is evidence that PAK1 isoforms may be functionally distinct [22,23] and that in melanoma, the predominant splicing pattern favors the creation of an enzymatically active PAK1 over a product of alternative splicing that encodes a truncated kinase domain (Isoform 2; Figure 2A) [24]. This evidence concerns the gene PAK1 and melanoma.